---
generated_at: '2026-02-11T15:58:03.814472+00:00'
grand_parent: NMN 2026-02-13
layout: default
nav_order: 202602
parent: 文獻薈萃
title: NMN文獻薈萃 2026-02
topic: nmn
total_articles: 839
---

# NMN文獻薈萃報告 — 2026 年 2 月

## 摘要

本月共收錄 NMN 相關文獻 839 篇，其中 Level 1 證據（Meta-Analysis/Systematic Review）9 篇，RCT 0 篇。

## 證據等級分布

| 證據等級 | 文獻數 | 佔比 |
|----------|--------|------|
| Level 1 (Meta-Analysis/Systematic Review) | 9 | 1.1% |
| Level 2 (RCT) | 0 | 0.0% |
| Level 3 (Clinical Trial) | 0 | 0.0% |
| Level 4 (Observational) | 0 | 0.0% |
| Level 5 (Review/Case Report/Other) | 830 | 98.9% |

## 功效分類統計

| 功效分類 | 中文 | 文獻數 | 佔比 |
|----------|------|--------|------|
| other | 其他 | 321 | 38.3% |
| metabolic | 代謝 | 200 | 23.8% |
| anti_aging | 抗衰老 | 192 | 22.9% |
| immune | 免疫調節 | 119 | 14.2% |
| cognitive | 認知功能 | 101 | 12.0% |
| cardiovascular | 心血管 | 100 | 11.9% |
| energy | 活力 | 66 | 7.9% |
| musculoskeletal | 肌肉骨骼 | 58 | 6.9% |
| digestive | 消化 | 42 | 5.0% |
| skin | 皮膚 | 29 | 3.5% |
| sexual | 性功能 | 20 | 2.4% |

## 成分搭配統計

| 成分 | 文獻數 |
|------|--------|
| nicotinamide mononucleotide | 470 |
| NMN | 440 |
| NAD+ | 80 |
| EPA | 80 |
| iron | 52 |
| stem cell | 30 |
| NAD precursor | 17 |
| fiber | 13 |
| collagen | 10 |
| glutathione | 9 |

## 成分組合分析

以下列出最常被共同研究的成分組合：

| 成分組合 | 共同出現文獻數 |
|----------|---------------|
| NMN + nicotinamide mononucleotide | 345 |
| NAD+ + nicotinamide mononucleotide | 66 |
| NAD+ + NMN | 62 |
| EPA + NMN | 57 |
| EPA + nicotinamide mononucleotide | 50 |
| iron + nicotinamide mononucleotide | 35 |
| NMN + iron | 33 |
| nicotinamide mononucleotide + stem cell | 20 |
| NMN + stem cell | 16 |
| NAD precursor + nicotinamide mononucleotide | 14 |

## 成分功效分析

以下列出主要成分在各功效領域的研究文獻數：

| 成分 | 總文獻 | 代謝 | 其他 | 抗衰老 | 免疫調節 | 認知功能 | 心血管 |
|------|--------|--------|--------|--------|--------|--------|--------|
| nicotinamide mononucleotide | 470 | 135 | 131 | 138 | 85 | 65 | 57 |
| NMN | 440 | 123 | 145 | 107 | 77 | 63 | 50 |
| NAD+ | 80 | 38 | 15 | 25 | 19 | 17 | 14 |
| EPA | 80 | 29 | 28 | 18 | 14 | 10 | 9 |
| iron | 52 | 18 | 9 | 14 | 16 | 10 | 11 |
| stem cell | 30 | 6 | 2 | 16 | 6 | 6 | 5 |
| NAD precursor | 17 | 9 | 4 | 8 | 2 | 3 | - |
| fiber | 13 | 1 | 9 | 2 | 1 | - | 1 |

## 研究類型分布

| 研究類型 | 文獻數 | 佔比 |
|----------|--------|------|
| Meta-Analysis | 6 | 0.7% |
| Systematic Review | 3 | 0.4% |
| RCT | 0 | 0.0% |
| Clinical Trial | 0 | 0.0% |
| Observational | 0 | 0.0% |
| Review | 0 | 0.0% |
| Case Report | 0 | 0.0% |
| Other | 830 | 98.9% |

## 近期重要文獻

### Level 1 證據（Meta-Analysis / Systematic Review）

1. **[Exercise training upregulates intracellular nicotinamide phosphoribosyltransferase expression in humans: a systematic review with meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/37954044/)** — Frontiers in public health, 
   - 功效分類：anti_aging

2. **[NAD⁺ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence.](https://pubmed.ncbi.nlm.nih.gov/41655607/)** — Ageing research reviews, 
   - 功效分類：anti_aging, immune

3. **[Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/39116016/)** — Critical reviews in food science and nutrition, 
   - 功效分類：cardiovascular, metabolic

4. **[Effects of Nicotinamide Mononucleotide Supplementation on Muscle and Liver Functions Among the Middle-aged and Elderly: A Systematic Review and Meta-analysis of Randomized Controlled Trials.](https://pubmed.ncbi.nlm.nih.gov/39185644/)** — Current pharmaceutical biotechnology, 
   - 功效分類：anti_aging, musculoskeletal

5. **[Improved Physical Performance Parameters in Patients Taking Nicotinamide Mononucleotide (NMN): A Systematic Review of Randomized Control Trials.](https://pubmed.ncbi.nlm.nih.gov/39221308/)** — Cureus, 
   - 功效分類：musculoskeletal, energy

